Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mithramycin suppresses tumor growth by regulating CD47 and PD-L1 expression
Jianhua Gong, Yuying Ji, Xiujun Liu, et al.
Biochemical Pharmacology (2021) Vol. 197, pp. 114894-114894
Closed Access | Times Cited: 13

Showing 13 citing articles:

Post-translational modifications of immune checkpoints: unlocking new potentials in cancer immunotherapy
Qiongjie Hu, Yueli Shi, Huang Wang, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access
Drug Repurposing of Selected Antibiotics: An Emerging Approach in Cancer Drug Discovery
Nilofer Bano, Sana Parveen, Mοhd Saeed, et al.
ACS Omega (2024) Vol. 9, Iss. 25, pp. 26762-26779
Open Access | Times Cited: 4
Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy
Jing Liu, Zhihao Zhao, Richard Zanni, et al.
ACS Nano (2025)
Closed Access
REMOVAL OF AMOXICILLIN THROUGH DIFFERENT METHODS, EMPHASIZING REMOVAL BY BIOPOLYMERS AND ITS DERIVATIVES. AN OVERVIEW
Francisca L. Aranda, Bernabé L. Rivas
Journal of the Chilean Chemical Society (2022) Vol. 67, Iss. 3, pp. 5643-5655
Open Access | Times Cited: 18
Is the new angel better than the old devil? Challenges and opportunities in CD47- SIRPα-based cancer therapy
Olamide Tosin Olaoba, Kehinde Sulaimon Ayinde, Olubodun M. Lateef, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 184, pp. 103939-103939
Closed Access | Times Cited: 10
Iron Deficiency Increases Phosphorylation of SP1 to Upregulate SPNS2 Expression in Hepatocellular Carcinoma
Dongyao Wang, Min Li, Hui Shen, et al.
Biological Trace Element Research (2022) Vol. 201, Iss. 4, pp. 1689-1694
Closed Access | Times Cited: 8
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy
Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 1
Modulation of Lymphocyte Functions in the Microenvironment by Tumor Oncogenic Pathways
Barbara Seliger, Chiara Massa
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Understanding the regulation of “Don’t Eat-Me” signals by inflammatory signaling pathways in the tumor microenvironment for more effective therapy
Ashkan Zare Karizak, Zahra Salmasi, Seyed Mohammad Gheibihayat, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 1, pp. 511-529
Closed Access | Times Cited: 6
Mithramycin and its analogs: Molecular features and antitumor action
José Portugal
Pharmacology & Therapeutics (2024) Vol. 260, pp. 108672-108672
Open Access
High-affinity decoy protein, nFD164, with an inactive Fc region as a potential therapeutic drug targeting CD47
Zhihong Wang, Naijing Hu, Haitao Wang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 162, pp. 114618-114618
Open Access | Times Cited: 1
[Latest Findings on the Role of CD47 in Tumor Immune Evasion and Related Targeted Therapies].
Xiao-Liang Jie, Yangyang Kong, Guang‐Biao Zhou
PubMed (2023) Vol. 54, Iss. 3, pp. 455-461
Closed Access | Times Cited: 1
The Expression of PD-L1, CD47, CD4, and CD8 in Breast Cancer before and after Neoadjuvant Chemotherapy and Their Relationship with Clinicopathological Features and Prognosis
Chenyu He, Mingzhi Zhu, Huifen Huang, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top